Comprehensive Healthcare Systems Inc
CHS
AIM6 Ventures Inc
AIMF.P
Athena Gold Corp
ATHA
Magna Terra Minerals Inc
MTT
Marksmen Energy Inc
MAH
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.11%274.92M | 64.12%259.97M | 28.06%224.95M | 23.62%842.43M | 61.07%265.31M | 45.92%243.06M | -5.64%158.41M | -3.66%175.65M | 13.61%681.49M | -17.20%164.72M |
Operating revenue | 13.11%274.92M | 64.12%259.97M | 28.06%224.95M | 23.62%842.43M | 61.07%265.31M | 45.92%243.06M | -5.64%158.41M | -3.66%175.65M | 13.61%681.49M | -17.20%164.72M |
Cost of revenue | 6.10%187.99M | 42.28%180.04M | 14.65%155.04M | 22.01%652.4M | 53.92%213.46M | 24.90%177.18M | -6.49%126.54M | 13.80%135.23M | 35.58%534.7M | -1.36%138.68M |
Gross profit | 31.96%86.93M | 150.83%79.93M | 72.92%69.91M | 29.45%190.03M | 99.12%51.85M | 166.59%65.88M | -2.08%31.87M | -36.34%40.43M | -28.56%146.8M | -55.37%26.04M |
Operating expense | 19.09%17.69M | 54.22%23.59M | 24.48%18.66M | 24.30%79.33M | 43.37%27.3M | 13.91%14.85M | -0.04%15.3M | -24.37%14.99M | -0.21%63.82M | -44.72%19.04M |
Operation and maintenance expenses | ---- | ---- | ---- | --3.5M | ---- | ---- | ---- | ---- | ---- | ---- |
Selling and administrative expenses | 9.64%16.04M | 53.66%22.42M | 21.97%18.23M | 4.26%64.07M | 19.39%19.91M | 12.22%14.63M | -1.57%14.59M | -11.68%14.95M | 35.49%61.46M | 1.39%16.68M |
-General and administrative expense | 9.64%16.04M | 53.66%22.42M | 21.97%18.23M | 4.26%64.07M | 19.39%19.91M | 12.22%14.63M | -1.57%14.59M | -11.68%14.95M | 35.49%61.46M | 1.39%16.68M |
Other operating expenses | 644.34%1.65M | 65.68%1.17M | 875.00%429K | 397.17%11.75M | --3.89M | --221K | 47.19%708K | -98.48%44K | -87.29%2.36M | ---- |
Operating profit | 35.70%69.24M | 240.00%56.34M | 101.47%51.25M | 33.41%110.7M | 250.79%24.56M | 337.13%51.03M | -3.89%16.57M | -41.77%25.44M | -41.37%82.98M | -70.72%7M |
Net non-operating interest income (expenses) | 23.04%-6.28M | -107.60%-5.71M | -135.62%-6.22M | -93.98%-18.8M | -508.70%-4.55M | -234.58%-8.16M | 26.19%-2.75M | 5.11%-2.64M | 10.39%-9.69M | 67.12%-747K |
Non-operating interest income | 40.72%1.37M | 4.18%773K | 29.18%850K | 97.41%3.65M | --1.28M | --970K | --742K | --658K | 0.27%1.85M | ---- |
Non-operating interest expense | -20.38%7.26M | 83.81%6.3M | 115.85%6.89M | 95.15%22.15M | 137.42%5.71M | 273.83%9.11M | -8.02%3.43M | 14.78%3.19M | -9.87%11.35M | -40.60%2.41M |
Total other finance cost | 2,869.23%386K | 181.54%183K | 69.52%178K | 57.51%304K | --121K | --13K | --65K | --105K | 179.71%193K | ---- |
Other net income (expenses) | 221.38%6.57M | 104.28%399K | 51.07%-1.47M | 48.11%-102.95M | 49.00%-92.82M | 28.87%-5.41M | -630.05%-9.31M | 58.05%-3M | -743.40%-198.39M | -2,229.85%-182.02M |
Gain on sale of security | 240.07%6.57M | 165.79%1.13M | 51.07%-1.47M | 103.12%261K | 87,754.55%9.66M | -17.11%-4.69M | -161.88%-1.72M | 58.05%-3M | 5.39%-8.37M | 100.20%11K |
Special income (charges) | --0 | ---- | ---- | 45.54%-103.21M | 44.07%-102.49M | 79.76%-722K | ---- | ---- | -1,190.91%-189.51M | -30,697.65%-183.25M |
-Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --6.4M | ---- | ---- | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | --0 | ---- | ---- | -48.81%96.6M | -47.67%95.88M | -78.63%722K | ---- | ---- | --188.72M | --183.21M |
-Gain on sale of property,plant,equipment | ---- | ---- | ---- | 73.51%-209K | ---- | ---- | ---- | ---- | ---789K | ---33K |
Other non-operating income (expenses) | ---- | 90.39%-730K | ---- | ---- | ---- | ---- | -701.37%-7.6M | ---- | ---521K | --1.22M |
Income before tax | 85.63%69.53M | 1,032.03%51.03M | 120.01%43.57M | 91.17%-11.05M | 58.57%-72.82M | 2,200.86%37.46M | -70.48%4.51M | -41.34%19.8M | -216.73%-125.11M | -682.35%-175.76M |
Income tax | 129.90%15.12M | 642.47%7.69M | 82.50%14.5M | 201.74%32.58M | 211.05%17.02M | 14.27%6.58M | -92.38%1.04M | 17.19%7.94M | -77.40%10.8M | -212.90%-15.33M |
Earnings from equity interest net of tax | ||||||||||
Net income | 76.21%54.42M | 1,148.27%43.34M | 145.15%29.07M | 67.90%-43.63M | 44.00%-89.84M | 848.50%30.88M | 106.79%3.47M | -56.05%11.86M | -328.80%-135.91M | -1,066.24%-160.43M |
Net income continuous operations | 76.21%54.42M | 1,148.27%43.34M | 145.15%29.07M | 67.90%-43.63M | 44.00%-89.84M | 848.50%30.88M | 106.79%3.47M | -56.05%11.86M | -328.80%-135.91M | -1,066.24%-160.43M |
Noncontrolling interests | 14.34%3.91M | 709.25%2.71M | 188.04%2.82M | 192.69%7.21M | 132.33%2.48M | 1,018.55%3.42M | 151.54%335K | 7.47%978K | -610.78%-7.77M | -993.01%-7.66M |
Net income attributable to the company | 83.90%50.51M | 1,195.15%40.63M | 141.29%26.25M | 60.33%-50.84M | 39.57%-92.32M | 831.65%27.47M | 34.69%3.14M | -58.26%10.88M | -321.39%-128.13M | -1,070.23%-152.77M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 83.90%50.51M | 1,195.15%40.63M | 141.29%26.25M | 60.33%-50.84M | 39.57%-92.32M | 831.65%27.47M | 34.69%3.14M | -58.26%10.88M | -321.39%-128.13M | -1,070.23%-152.77M |
Diluted earnings per share | 77.78%0.16 | 1,200.00%0.13 | 125.00%0.09 | 61.36%-0.17 | 40.89%-0.31 | 798.70%0.09 | 0.00%0.01 | -55.56%0.04 | -283.33%-0.44 | -1,148.97%-0.5245 |
Basic earnings per share | 77.78%0.16 | 1,200.00%0.13 | 125.00%0.09 | 61.36%-0.17 | 40.89%-0.31 | 798.70%0.09 | 0.00%0.01 | -55.56%0.04 | -291.30%-0.44 | -1,411.21%-0.5245 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.